Brand Name:
MYRICA GV 2.2
MYRICA GV 2.2 Tablet | Glimepiride 2 mg + Metformin 500 mg SR + Voglibose 0.2 mg
Drug
10X15
Categories:
TABLETS
Cardiac Diabetic
Contains Glimepiride 2 mg
Contains Metformin 500 mg SR
Contains Voglibose 0.2 mg
Triple-combination therapy for Type 2 Diabetes
Supports insulin secretion
Helps improve insulin sensitivity
Helps reduce hepatic glucose production
Helps manage post-meal blood glucose levels
Sustained-release Metformin formulation
MYRICA GV 2.2 Tablet combines Glimepiride 2 mg, Metformin 500 mg SR, and Voglibose 0.2 mg for blood glucose management in adults with Type 2 Diabetes. Glimepiride supports insulin release, Metformin helps improve insulin sensitivity and reduce hepatic glucose production, while Voglibose delays carbohydrate digestion and helps control post-meal glucose levels. Take only as prescribed by your healthcare professional.
Glimipride 2 Mg, Metformin 500 Mg (Sr) Voglibose 0.2 Mg
Related products
-

MYRICA G1 Tablet | Glimepiride 1 mg + Metformin 500 mg SR
₹1,250.00 View Details -

VIDAGEN-M FORTE Tablet | Vildagliptin 50 mg + Metformin 1000 mg
₹2,109.30 View Details -

VIDAGEN-50 Tablet | Vildagliptin 50 mg | Type 2 Diabetes Management
₹1,440.00 View Details -

NERF PLUS Capsule | Methylcobalamin + Alpha Lipoic Acid + Benfotiamine
₹2,680.00 View Details


